nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration

nb单核细胞的先天免疫反应:对神经退行性变的贡献

基本信息

项目摘要

Disruption of Innate Immunity Responses in Monocytes: Contribution to Neurodegeneration ABSTRACT Alzheimer’s disease (AD), characterized by elevated levels of β-amyloid (Aβ40 and Aβ42), is the leading cause of dementia, prevailing in approximately 12% of the population worldwide. In turn, HIV-associated neurocognitive disorders (HAND) prevail in 20-50% of people with HIV (PWH)1,2, despite the access to combined antiretroviral therapy (cART). Monocyte recruitment to the brain promotes macrophage phagocytic clearance of Aβ plaques and restoration of central nervous system (CNS) homeostasis (reviewed in3). However, in HIV infection, peripheral monocytes infiltrate the compromised blood brain barrier (BBB) into the CNS, triggering inflammation and neuronal damage4–7. Interestingly, HAND patients exhibit accumulation of Aβ in the blood8 and in the brain9–12, despite the presence of infiltrated monocytes. HIV hijacks its target cells to promote viral replication by impairing the interferon type I (IFN-1) signaling13,14. In AD, altered IFN-1 response decreases the recruitment of monocytes to the CNS15. IFN-1 signaling impairs insulin production16– 18, and dysregulated insulin signaling exacerbates Aβ plaque formation19,20. In turn, elevated levels of Aβ contribute to insulin resistance and cognitive decline21. In HIV patients on cART, insulin resistance prevalence is higher, compared to healthy individuals, which in turn is associated with worse neuropsychological performance, suggesting that metabolic alterations could also contribute to the development of HAND22,23. Thus, Aβ metabolism, insulin signaling, and cognitive impairment are interconnected. Due to their different etiologies, the shared mechanisms underlying AD pathology and HIV neuropathogenesis are not well understood. I hypothesize that impaired IFN-1 signaling in monocyte/macrophage (Mφs) alters their phenotype and insulin receptor (IR) metabolism, contributing to cognitive impairment in HAND and in AD patients. In this study, I will determine the contribution of the Mφs IFN-1 response to cognitive decline, through the following aims: 1) Characterization of IFN-1 signaling and insulin receptor biology in monocytes from the blood of AD and HAND patients, stratified by cognitive status; 2) using brain organoid models I will determine whether monocytes are neuroprotective or neuroinflammatory upon HIV infection, using HIV-negative and positive subjects’ monocytes; 3) I will determine the effect(s) of IFN-1 receptor modulation on Mφs phenotype, and neuronal dysfunction in vitro using brain organoids. Results from this study will uncover novel mechanisms involved in the crosstalk between the peripheral and CNS in neurodegenerative disorders. Further, our results will help identifying candidates and/or targets for the development of effective therapies against cognitive decline in HAND andAD. The proposed training plan is tailored to capitalize on my expertise in cellular biology and viral immunology, and to expand my skill set with novel 3D brain organoids methodologies. The multidisciplinary mentoring team is committed to provide career guidance, enrich my knowledge on new techniques, and ensure my transition to independence in academia, specializing in neuroimmunology.
单核细胞中先天免疫反应的破坏:对神经变性的贡献 抽象的 阿尔茨海默氏病(AD),其特征是β-淀粉样蛋白水平升高(Aβ40和Aβ42)是主要原因 痴呆症,大约在全球大约12%的人口 神经认知障碍(手)占艾滋病毒(PWH)1,2的20-50%,尽管可以使用 抗逆转录病治疗(CART)。 Aβ斑块的清除和中枢神经系统(CNS)体内平衡的修复(审查为3)。 霍弗(Howver),在艾滋病毒感染中,周围单核细胞渗入折衷的血屏(BBB)中 中枢神经系统触发炎症和神经元损害4-7。 尽管存在浸润的单核细胞,但血液8和脑9-12中的Aβ。 通过损害I型I型(IFN-1)信号13,14来促进病毒复制。 Sunperoney将单核细胞募集到CNS15。 18和失调的胰岛素信号传导加剧了Aβ斑块的形成19,20。 胰岛素抵抗和认知下降21。 与健康个体相比,较高的人又与较差的神经心理学有关 表现,表明代谢改变CANO有助于手的发展2,23。 因此,由于它们的不同,Aβ代谢,胰岛素信号传导和认知障碍因其不同而互连。 病因,AD病理学和HIB神经病的基础的共享机制不是很好 理解。 表型和胰岛素受体(IR)代谢,有助于手头和AD认知障碍 在这项研究中,我将设计MφSIFN-1对认知能力下降的贡献 以下AMS:1)来自您的单核细胞中IFN-1信号传导和胰岛素受体生物学的表征 AD手手患者的血液,通过认知状态分层; 2)使用脑器官 单核细胞是在HIV阴性和 阳性受试者的单核细胞; 使用脑器官的体外神经元功能障碍。 在神经退行性疾病中参与周围和中枢神经系统之间的crostalk。 将有助于确定候选人和/或目标,以开发有效的认知疗法 降低了手动培训计划,以利用我的实验生物学 和病毒式IMUNOLOGY,并通过新颖的3D脑器官方法扩展了我的技能 多学科指导团队致力于提供职业指导,丰富我对新知识 技术,并确保我过渡到学术界的独立性,专门研究神经免疫学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yisel M. Cantres-Rosario其他文献

Yisel M. Cantres-Rosario的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yisel M. Cantres-Rosario', 18)}}的其他基金

nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration
nb单核细胞的先天免疫反应:对神经退行性疾病的贡献
  • 批准号:
    10899788
  • 财政年份:
    2021
  • 资助金额:
    $ 11.58万
  • 项目类别:
nbInnate Immunity Responses In Monocytes: Contribution To Neurodegeneration
nb单核细胞的先天免疫反应:对神经退行性变的贡献
  • 批准号:
    10455617
  • 财政年份:
    2021
  • 资助金额:
    $ 11.58万
  • 项目类别:

相似海外基金

Mechanistic dissection of allosteric modulation and nonproteolytic chaperone activity of human insulin-degrading enzyme
人胰岛素降解酶变构调节和非蛋白水解伴侣活性的机制剖析
  • 批准号:
    10667987
  • 财政年份:
    2023
  • 资助金额:
    $ 11.58万
  • 项目类别:
Astrocytic exocytosis of ATP in amyloid pathology and Alzheimer's disease
淀粉样蛋白病理学和阿尔茨海默病中 ATP 的星形细胞胞吐作用
  • 批准号:
    10722422
  • 财政年份:
    2023
  • 资助金额:
    $ 11.58万
  • 项目类别:
Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease
脑血管线粒体作为阿尔茨海默病神经炎症的介质
  • 批准号:
    10723580
  • 财政年份:
    2023
  • 资助金额:
    $ 11.58万
  • 项目类别:
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
  • 批准号:
    10713025
  • 财政年份:
    2023
  • 资助金额:
    $ 11.58万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 11.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了